Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352Phase 4Terminated
- Sponsor
- CHR Metz-Thionville
- Start
- Mar 2022
- Primary completion
- Jul 2024
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 4 trial of dermatophagoides pteronyssinus in allergic rhinitis (AR), sponsored by CHR Metz-Thionville. Started Mar 2022; status: terminated.
02
Drugs
dermatophagoides pteronyssinus
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04915352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04915352.